Literature DB >> 14983875

Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production.

Erica A Marieb1, Alexandra Zoltan-Jones, Rongsong Li, Suniti Misra, Shibnath Ghatak, Jian Cao, Stanley Zucker, Bryan P Toole.   

Abstract

Emmprin (CD147; basigin) is a plasma membrane glycoprotein, enriched on the surface of many cancer cells, which induces matrix metalloproteinase synthesis via cell-cell interactions. Elevated emmprin production causes increased growth in vivo of human mammary carcinoma cells. In this study, we show that elevation of emmprin expression in less aggressive human carcinoma cells, which normally express low emmprin levels, induces the ability to grow under anchorage-independent conditions. We also found that elevated emmprin expression stimulates hyaluronan production and that the effect of emmprin on anchorage-independent growth is dependent on hyaluronan. Furthermore, emmprin stimulates cell survival pathway signaling in a hyaluronan-dependent manner. From these and other studies we conclude that emmprin enhances several malignant properties of cancer cells, including anchorage-independent growth, invasiveness, and chemoresistance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14983875     DOI: 10.1158/0008-5472.can-03-2832

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  69 in total

1.  CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer.

Authors:  Yi-Jun Xue; Qiang Lu; Zhi-Xi Sun
Journal:  Med Oncol       Date:  2010-05-28       Impact factor: 3.064

2.  Induction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients.

Authors:  Lu Dai; Yihan Chen; Karlie Bonstaff; Lisa Doyle; Bryan Toole; Chris Parsons; Zhiqiang Qin
Journal:  Cancer Lett       Date:  2015-03-30       Impact factor: 8.679

3.  Cluster of differentiation 147 mediates chemoresistance in breast cancer by affecting vacuolar H+-ATPase expression and activity.

Authors:  Yehong Kuang; Shouman Wang; Lili Tang; Jian Hai; Guojiao Yan; Liqiu Liao
Journal:  Oncol Lett       Date:  2018-03-07       Impact factor: 2.967

4.  Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells.

Authors:  Mark G Slomiany; G Daniel Grass; Angela D Robertson; Xiao Y Yang; Bernard L Maria; Craig Beeson; Bryan P Toole
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

5.  EMMPRIN/CD147 expression is associated with disease-free survival of patients with colorectal cancer.

Authors:  Shaojun Zhu; Dake Chu; Yang Zhang; Xuxia Wang; Li Gong; Xiujuan Han; Li Yao; Miao Lan; Yanhong Li; Wei Zhang
Journal:  Med Oncol       Date:  2013-02-07       Impact factor: 3.064

6.  Interaction of monocarboxylate transporter 4 with beta1-integrin and its role in cell migration.

Authors:  Shannon M Gallagher; John J Castorino; Nancy J Philp
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-10       Impact factor: 4.249

Review 7.  CD147 and glioma: a meta-analysis.

Authors:  Hui Li; Zhouhuan Xi; Xuejiao Dai; Wenyue Wu; Yanwen Li; Yanting Liu; Hanwen Zhang
Journal:  J Neurooncol       Date:  2017-05-30       Impact factor: 4.130

8.  Co-expression of CD147 and GLUT-1 indicates radiation resistance and poor prognosis in cervical squamous cell carcinoma.

Authors:  Xin-Qiong Huang; Xiang Chen; Xiao-Xue Xie; Qin Zhou; Kai Li; Shan Li; Liang-Fang Shen; Juan Su
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

Review 9.  Targeting hyaluronan interactions in spinal cord astrocytomas and diffuse pontine gliomas.

Authors:  Bernard L Maria; Nalin Gupta; Anne G Gilg; May Abdel-Wahab; Anthony P Leonard; Mark Slomiany; William G Wheeler; Lauren B Tolliver; Michael A Babcock; John T Lucas; Bryan P Toole
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

10.  Prediction of prognosis in gallbladder carcinoma by CD147 and MMP-2 immunohistochemistry.

Authors:  Wei Wu; Rongbing Wang; Hui Liu; Jie Peng; Damao Huang; Bo Li; Jingde Ruan
Journal:  Med Oncol       Date:  2008-07-30       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.